Table 4. Interaction between carbon black (CB) and lipopolysaccharide (LPS).
CB dilution (μg/ml) | ||||||||||
Replicate | 25.6 | 12.8 | 8.3 | 6.4 | 4.3 | 3.2 | 2.1 | 1.1 | 0.5 | LPS-free water |
1 | + | + | + | + | + | - | - | - | - | - |
2 | + | + | + | + | + | + | - | - | - | - |
Low-dose CB+LPS dilution (μg/ml) / (EU/ml) | ||||||||||
Replicate | 8.5 / 1000 | 4.3 / 500 | 2.1 / 250 | 1.1 / 125 | 0.5 / 62.5 | LPS-free water | ||||
1 | + | + | + | + | - | - | ||||
2 | + | + | + | + | - | - | ||||
High-dose CB+LPS dilution (μg/mL) / (EU/ml) | ||||||||||
Replicate | 25.6 / 1000 | 12.8 / 500 | 6.4 / 250 | 3.2 / 125 | 1.6 / 62.5 | LPS-free water | ||||
1 | - | - | - | - | - | - | ||||
2 | - | - | - | - | - | - |
Nanosized CB was sonicated in LPS free water and diluted in LPS free water to the concentration used for in vivo study exposure (the highest concentration of low-dose (8.5 μg/mouse), and high-dose (25.6 μg/mouse)). Each assay was performed in duplicates. “+” indicates a clot equals LPS in the sample, and “–”indicates no-clot that is equal to no LPS in the sample.